Franz Eberli
Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
Foster-Witassek F, Rickli H, Roffi M, Pedrazzini G, Eberli F, Fassa A, Jeger R, Fournier S, Erne P, Radovanovic D. Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction. Eur J Prev Cardiol 2022
13.12.2022Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
13.12.2022Eur J Prev Cardiol 2022
Foster-Witassek Fabienne, Rickli Hans, Roffi Marco, Pedrazzini Giovanni, Eberli Franz, Fassa Amir, Jeger Raban, Fournier Stephane, Erne Paul, Radovanovic Dragana
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
Tersalvi G, Erne P, Moccetti T, Jeger R, Moccetti M, Eberli F, Roffi M, Rickli H, Radovanovic D, Biasco L, Pedrazzini G. Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry. Cardiology 2020; 145:757-765.
20.08.2020Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
20.08.2020Cardiology 2020; 145:757-765
Tersalvi Gregorio, Erne Paul, Moccetti Tiziano, Jeger Raban, Moccetti Marco, Eberli Franz, Roffi Marco, Rickli Hans, Radovanovic Dragana, Biasco Luigi, Pedrazzini Giovanni
Impact of cardiac rehabilitation participation on patient-reported lifestyle changes one year after myocardial infarction
Hermann M, Rickli H, Radovanovic D, Maggiorini M, Roffi M, Muller O, Eberli F, Erne P, Witassek F, AMIS Plus Investigators. Impact of cardiac rehabilitation participation on patient-reported lifestyle changes one year after myocardial infarction. Eur J Prev Cardiol 2019:2047487319895429.
16.12.2019Impact of cardiac rehabilitation participation on patient-reported lifestyle changes one year after myocardial infarction
16.12.2019Eur J Prev Cardiol 2019:2047487319895429
Hermann Matthias, Rickli Hans, Radovanovic Dragana, Maggiorini Marco, Roffi Marco, Muller Olivier, Eberli Franz, Erne Paul, Witassek Fabienne, AMIS Plus Investigators
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
Jeger R, Weilenmann D, Rickli H, Hansen K, Rickenbacher P, Conen D, Müller C, Osswald S, Gilgen N, Vuilliomenet A, Pedrazzini G, Pfisterer M, Vogt D, Galatius S, Abildgaard U, Naber C, Alber H, Eberli F, Kurz D, Kaiser C. Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II. PloS one 2019; 14:e0210821.
15.01.2019Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
15.01.2019PloS one 2019; 14:e0210821
Jeger Raban V, Weilenmann Daniel, Rickli Hans, Hansen Kim Wadt, Rickenbacher Peter, Conen David, Müller Christian, Osswald Stefan, Gilgen Nicole, Vuilliomenet André, Pedrazzini Giovanni, Pfisterer Matthias, Vogt Deborah R, Galatius Søren, Abildgaard Ulrik, Naber Christoph, Alber Hannes, Eberli Franz, Kurz David J, Kaiser Christoph
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
Biasco L, Erne P, Moccetti T, Jeger R, Eberli F, Roffi M, Rickli H, Moccetti M, Radovanovic D, Pedrazzini G. New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed) 2018
10.04.2018New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
10.04.2018Rev Esp Cardiol (Engl Ed) 2018
Biasco Luigi, Erne Paul, Moccetti Tiziano, Jeger Raban, Eberli Franz, Roffi Marco, Rickli Hans, Moccetti Marco, Radovanovic Dragana, Pedrazzini Giovanni
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
Vassalli G, Pedrazzini G, Pfisterer M, Kaiser C, Moccetti T, Bonetti P, Bertel O, Hornig B, Rickli H, Eberli F, Erne P, Galatius S, De Servi S, Klersy C, BASKET-PROVE Investigators. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. Am Heart J 2015; 173:1-7.
01.12.2015Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
01.12.2015Am Heart J 2015; 173:1-7
Vassalli Giuseppe, Pedrazzini Giovanni, Pfisterer Matthias, Kaiser Christoph, Moccetti Tiziano, Bonetti Piero, Bertel Osmund, Hornig Burkhard, Rickli Hans, Eberli Franz, Erne Paul, Galatius Soeren, De Servi Stefano, Klersy Catherine, BASKET-PROVE Investigators
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Kaiser C, Vuillomenet A, Steiner M, von Felten S, Vogt D, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, Weilenmann D, Rickli H, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz D, Pedrazzini G, Moccetti T, BASKET-PROVE II study group. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014; 131:74-81.
19.11.2014Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
19.11.2014Circulation 2014; 131:74-81
Kaiser Christoph, Vuillomenet André, Steiner Martin, von Felten Stefanie, Vogt Deborah R, Wadt Hansen Kim, Rickenbacher Peter, Conen David, Müller Christian, Buser Peter, Hoffmann Andreas, Pfisterer Matthias, Weilenmann Daniel, Rickli Hans, Galatius Soeren, Jeger Raban, Gilgen Nicole, Skov Jensen Jan, Naber Christoph, Alber Hannes, Wanitschek Maria, Eberli Franz, Kurz David J, Pedrazzini Giovanni, Moccetti Tiziano, BASKET-PROVE II study group
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
Jeger R, Kaiser C, Galatius S, Rickli H, Pedrazzini G, Erne P, Eberli F, Bonetti P, Alber H, von Felten S, Sørensen R, Pfisterer M, BASKET and BASKET-PROVE investigators. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. Am Heart J 2014; 168:698-705.
30.07.2014Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
30.07.2014Am Heart J 2014; 168:698-705
Jeger Raban V, Kaiser Christoph A, Galatius Søren, Rickli Hans, Pedrazzini Giovanni, Erne Paul, Eberli Franz, Bonetti Piero O, Alber Hannes, von Felten Stefanie, Sørensen Rikke, Pfisterer Matthias E, BASKET and BASKET-PROVE investigators
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
Jeger R, Gilgen N, Vuilliomenet A, Jensen J, Rickli H, Pedrazzini G, Naber C, Galatius S, Eberli F, Alber H, Pfisterer M, Kaiser C. Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design. Am Heart J 2012; 163:136-41.e1.
01.02.2012Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
01.02.2012Am Heart J 2012; 163:136-41.e1
Jeger Raban, Gilgen Nicole, Vuilliomenet André, Jensen Jan Skov, Rickli Hans, Pedrazzini Giovanni, Naber Christoph, Galatius Søren, Eberli Franz, Alber Hannes, Pfisterer Matthias, Kaiser Christoph
Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience
Pedrazzini G, Erne P, Rickli H, Windecker S, Urban P, Eberli F, Moccetti T, Sürder D, Vassalli G, Radovanovic D, AMIS Plus Investigators. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Cardiovasc Interv 2011; 4:627-33.
01.06.2011Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience
01.06.2011JACC Cardiovasc Interv 2011; 4:627-33
Pedrazzini Giovanni B, Erne Paul, Rickli Hans, Windecker Stephan, Urban Philip, Eberli Franz, Moccetti Tiziano, Sürder Daniel, Vassalli Giuseppe, Radovanovic Dragana, AMIS Plus Investigators
Drug-eluting versus bare-metal stents in large coronary arteries
Kaiser C, Pfisterer M, Ricard I, Brunner-La Rocca H, De Servi S, Bonetti P, Bertel O, Hornig B, Pedrazzini G, Rickli H, Alber H, Eberli F, Erne P, Galatius S, BASKET?PROVE Study Group. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010; 363:2310-9.
16.11.2010Drug-eluting versus bare-metal stents in large coronary arteries
16.11.2010N Engl J Med 2010; 363:2310-9
Kaiser Christoph, Pfisterer Matthias, Ricard Ingrid, Brunner-La Rocca Hans-Peter, De Servi Stefano, Bonetti Piero, Bertel Osmund, Hornig Burkhard, Pedrazzini Giovanni, Rickli Hans, Alber Hannes, Eberli Franz, Erne Paul, Galatius Soeren, BASKET?PROVE Study Group
Impact of clopidogrel in coronary artery bypass grafting
Englberger L, Portocarrero Vivero-Fäh B, Berdat P, Eberli F, Meier B, Carrel T. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2004; 26:96-101.
01.07.2004Impact of clopidogrel in coronary artery bypass grafting
01.07.2004Eur J Cardiothorac Surg. 2004; 26:96-101
Englberger Lars, Portocarrero Vivero-Fäh Bettina, Berdat Pascal A, Eberli Franz, Meier Bernhard, Carrel Thierry